Malaysia conducts health survey:
This article was originally published in Clinica
A survey of disease demographics is being carried out in Malaysia to assist in planning national healthcare policies, reports Asian Medical News. Some 90,000 people are expected to be included in the survey.
You may also be interested in...
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
The first of around 260 patients for a clinical trial comparing its PB006 natalizumab biosimilar candidate to Biogen’s Tysabri reference brand have been recruited by Polpharma Biologics, which has just added Karsten Roth and Alexandra Moulson to its team.